Author: Fedora Pharmaceuticals, Inc.

Posted Date:

April 20, 2026

Fedora Pharmaceuticals Presentations at 2026 ESCMID Highlight Safety and Potent Bactericidal Activity of FPI-2119

Fedora Pharmaceuticals, Inc.

April 20, 2026
Fedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress

Fedora Pharmaceuticals, Inc.

April 9, 2026
Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference

Fedora Pharmaceuticals, Inc.

January 29, 2026